Pasithea Therapeutics Corp. (KTTA) NASDAQ
0.68
-0.0395(-5.52%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.68
-0.0395(-5.52%)
Currency In USD
Address
1111 Lincoln Road
Miami Beach, FL 33139
United States of America (the)
Phone
702 514 4174
Website
Sector
Healthcare
Industry
Biotechnology
Employees
4
First IPO Date
September 15, 2021
| Name | Title | Pay | Year Born |
| Tiago Reis Marques | Chief Executive Officer & Director | 1.05M | 1978 |
| Lawrence Steinman | Co-Founder & Executive Chairman | 208,751 | 1948 |
| Daniel H. Schneiderman | Chief Financial Officer | 716,884 | 1978 |
| Kartik Krishnan | Chief Medical Officer | 0 | N/A |
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.